| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |